Headline: Latest Weight-Loss Drug Faces Shortages
Caption:
The United States Food and Drug Administration (FDA) says that high demand has left the latest weight-loss drug, Zepbound, in short supply.
'Newsweek' reports that the Eli Lilly product is expected to experience limited availability through Q2 of 2024 as surging demand has outpaced the manufacturer's expectations.
Keywords: Latest,Weight,Loss,Drug,Faces,Shortages,Food and Drug Administration,FDA,Zepbound,Shortly,Supply,Demand,Medicine,Eli Lilly,Outpaced,Manufacturer,Expections,Novo Nordisk,Wegovy,Incretin,Mimics,Gut Hormones,Appetite,Diabetes,Obesity
PersonInImage: